MGN Laboratories a portfolio company of HealthEdge has been sold to LabCorp
Client: Healthedge Investment Partners
Client Location: U.S.
Target: MNG Laboritories
Target Location: U.S.
Buyer: Laboratory Corporation of America
Buyer Location: U.S.
Target Description: MNG is a leading clinical diagnostic provider specializing in neurogenetic and complex biochemical testing.
Meet our Senior Team
View More Transactions in Healthcare
Lincoln International is pleased to announce that Gruppo Sapio has acquired a majority stake in Homeperf . Parquest Capital, BNP Paribas Développement and Arkea Capital will reinvest in the business alongside Sapio
Lincoln International is pleased to announce that it has advised IntegriChain, Inc. on the acquisition of the life sciences division of Cumberland
Lincoln International is pleased to announce the sale of substantially all of the operating assets of Valeritas Holdings, Inc. (NASDAQ:VLRX) pursuant to Section 363 of the U.S. Bankruptcy Code to Zealand Pharma A/S (NASDAQ:ZEAL)
Lincoln International is pleased to announce that it represented Flexpoint Ford on its acquisition of MGA Homecare